P

PureTech Health

PRTCNASDAQ

PureTech Health is a publicly traded company on NASDAQ. As of Q3 2025, 7 institutional investors hold shares in this company, with total holdings valued at $20.6M. LANSDOWNE PARTNERS LLP is the largest holder with a position valued at $18.8M.

Employees90.0

Overview

Overview of institutional ownership in PRTC as of Q3 2025

All Institutions

Institutions
7
Value Held
$20.6M
Shares Held
14.2M
Avg Position
$2.9M
Median Position
$135.5K

Hedge Funds

Hedge Funds
4
Value Held
$20.6M
Shares Held
14.2M
Avg Position
$5.2M
Median Position
$858.0K

Biggest Investors

Institutions with the largest positions in PRTC as of Q3 2025

InstitutionPosition Value
LANSDOWNE PARTNERS  LLP logo
LANSDOWNE PARTNERS LLP
Hedge FundLong/Short
$18.8M
1.56% of portfolio
Pentwater Capital Management LP logo
Pentwater Capital Management LP
Hedge FundEvent Driven
$1.4M
0.01% of portfolio
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
$328.5K
0.00% of portfolio
DIADEMA PARTNERS LP logo
DIADEMA PARTNERS LP
Hedge FundLong/Short
$135.5K
0.09% of portfolio
$31.2K
0.02% of portfolio
UBS Group AG logo
UBS Group AG
Institution
$370.0
0.00% of portfolio
$37.0
0.00% of portfolio
-
0.00% of portfolio
Portolan Capital Management, LLC logo
Portolan Capital Management, LLC
Hedge FundLong/Short
-
0.00% of portfolio
-
0.00% of portfolio

Net Capital Flow

Institutional buying and selling activity for PRTC in Q3 2025

Traded
+$18.2M
Buyers
3
Sellers
4
Total Bought
+$19.2M
Total Sold
$1.0M
Avg Position
$2.1M

Biggest Buyers

InstitutionNet Bought
LANSDOWNE PARTNERS  LLP logo
LANSDOWNE PARTNERS LLP
Hedge FundLong/Short
+$18.8M
+14.1M shares
Pentwater Capital Management LP logo
Pentwater Capital Management LP
Hedge FundEvent Driven
+$462.5K
+25.0K shares
+$37.0
+2.0 shares

Biggest Sellers

InstitutionNet Sold
Portolan Capital Management, LLC logo
Portolan Capital Management, LLC
Hedge FundLong/Short
$479.5K
27.8K shares
$415.3K
242.7K shares
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
$110.8K
6.0K shares
$2.0K
115.0 shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited PRTC in Q3 2025

New Positions
2
New Value
$18.8M
Exited Positions
3
Exited Value
$896.8K

New Positions

InstitutionPosition Value
LANSDOWNE PARTNERS  LLP logo
LANSDOWNE PARTNERS LLP
Hedge FundLong/Short
$18.8M
14.1M shares
$37.0
2.0 shares

Exited Positions

InstitutionPrevious Position
Portolan Capital Management, LLC logo
Portolan Capital Management, LLC
Hedge FundLong/Short
$479.5K
27.8K shares
$415.3K
242.7K shares
$2.0K
115.0 shares

Options Activity

Institutions with the largest Call and Put options positions in PRTC as of Q3 2025

Call Positions
0
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
No call positions found

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with PRTC as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
LANSDOWNE PARTNERS  LLP logo
LANSDOWNE PARTNERS LLP
Hedge FundLong/Short
1.56%
$18.8M
DIADEMA PARTNERS LP logo
DIADEMA PARTNERS LP
Hedge FundLong/Short
0.09%
$135.5K
0.02%
$31.2K
Pentwater Capital Management LP logo
Pentwater Capital Management LP
Hedge FundEvent Driven
0.01%
$1.4M
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
0.00%
$328.5K
0.00%
$37.0
UBS Group AG logo
UBS Group AG
Institution
0.00%
$370.0
0.00%
-
Portolan Capital Management, LLC logo
Portolan Capital Management, LLC
Hedge FundLong/Short
0.00%
-
0.00%
-

Hedge Fund Spotlight

Discover hedge funds investing in PRTC

DIADEMA PARTNERS LP logo
DIADEMA PARTNERS LP
Hedge FundLong/Short
Portfolio ManagerTimothy Beau Bassett
Portfolio Value
$143.3M
Positions
58
Last Reported
Q3 2025
AddressMorristown, NJ
Sector Allocation
Healthcare: 89.10%Healthcare
P

Position in PureTech Health

Market Value
$135.5K
Shares Held
7.3K
Portfolio Weight
0.09%
Owned Since
2025-Q2
Top HoldingSectorMarket ValueWeight
Biotechnology
Healthcare
$17.0M11.83%
Biotechnology
Healthcare
$12.0M8.36%
Biotechnology
Healthcare
$11.5M8.05%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.